Skip to main content
Premium Trial:

Request an Annual Quote

Former 3rd Millennium Exec to Lead Bioinformatics at Beyond Genomics

NEW YORK, June 8 - Beyond Genomics has hired Eric Neumann, formerly a vice president at 3 rd  Millennium, to the position of vice president of bioinformatics, the company said Friday.

 

At Beyond Genomics, a startup company hoping to commercialize a systems approach to drug discovery, Neumann will be in charge of the scientific and commercial development of the company's bioinformatics platform, according to a statement.

 

Prior to joining Beyond Genomics, Neumann served as vice president of life science informatics at 3 rd Millennium, a bioinformatics consulting group. During his 15 years in bioinformatics, he has also worked at NetGenics and other companies including Bolt, Beranek, and Newman, now a part of Verizon Wireless. Neumann also serves as an advisor to Sun MicroSystem's Life Sciences Open-Platform Initiative.

 

"We are delighted to have a bioinformatics industry veteran like Eric join our team," Stephen Ober, president of Beyond Genomics, said in a statement. "He has a proven track record of developing both models and integrative pathway data solutions that will be the cornerstone of our bioinformatics platform."

 

In May, Beyond Genomics signed a a two-year deal with Elan Pharmaceuticals to search for biomarkers and drug targets associated with Alzheimer's disease, in return for a $5 million equity investment from Elan.

 

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.